Dr. Gary K Ludwig, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 130 2nd St, Neenah, WI 54956 Phone: 920-729-2500 Fax: 920-729-3031 |
Rebecca Buell-gutbrod, Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 130 2nd St, Neenah, WI 54956 Phone: 920-729-3100 |
Dr. Mona S Hermina, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 130 2nd St, Neenah, WI 54956 Phone: 920-738-6315 Fax: 920-729-3031 |
Dr. Tiffany E Corrigan, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 130 2nd St, Neenah, WI 54956 Phone: 920-729-2499 Fax: 920-729-3031 |
Dr. Amy Marie Sheldon, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Medicare Enrolled Practice Location: 130 2nd St, Neenah, WI 54956 Phone: 920-729-3100 Fax: 920-923-5260 |
Dr. Karla M Sendelbach-elizondo, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 130 2nd St, Neenah, WI 54956 Phone: 920-738-6297 Fax: 920-738-6438 |
Dr. Sara Mcclintock-treep, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 130 2nd St, Neenah, WI 54956 Phone: 920-729-2739 Fax: 920-729-3006 |
News Archive
What do we really know about the relationship between the experience of pain and risk of developing opioid use disorder? Results from a recent study - the first to directly address this question - show that people with moderate or more severe pain had a 41 percent higher risk of developing prescription opioid use disorders than those without, independent of other demographic and clinical factors.
VOA News reports on global efforts to eradicate polio, writing, "Experts say with India now polio-free and the total number of cases at the lowest level ever, this is an opportunity to change history and eradicate the disease entirely."
In 2012, Dr. Nir Krakauer, an assistant professor of civil engineering in CCNY's Grove School of Engineering, and his father, Dr. Jesse Krakauer, MD, developed a new method to quantify the risk specifically associated with abdominal obesity.
Biotechnology company MabCure, Inc. today announced that a confirmatory study demonstrated the company's proprietary monoclonal antibodies (MAbs) successfully identified ovarian cancer in blood (94 percent accuracy) and with no false positives or cross-reactions with benign ovarian tumors or healthy blood. MabCure's serum diagnostic test is the first to recognize unique tumor markers or cancer fingerprints present only in ovarian cancer, the deadliest of all gynecological cancers.
› Verified 3 days ago